Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with...

Area of Science:

• Cellular Biology
• Neuroscience
• Biochemistry

Background:

• Mitochondria generate cellular energy via oxidative phosphorylation (OXPHOS).
• OXPHOS is crucial for neuronal functions like development, connectivity, and plasticity.
• Mitochondrial dysfunction is linked to various psychiatric disorders, including schizophrenia (SCZ).

Purpose of the Study:

• To review evidence linking OXPHOS dysfunction to the pathophysiology of SCZ.
• To highlight the role of mitochondrial energy production in SCZ.

Main Methods:

• Review of imaging, transcriptomic, proteomic, and metabolomic studies.
• Analysis of cellular signaling pathways and gene expression related to OXPHOS.
• Examination of Complex I interactions with dopamine and antipsychotic drugs.

Main Results:

• Evidence points to OXPHOS deficits in SCZ patients.
• Abnormalities observed in high-energy phosphates, OXPHOS complex activity, and gene expression (especially Complex I).
• Impaired cellular signaling (cAMP/PKA, Ca+2) and neuronal functions are associated with OXPHOS dysfunction in SCZ.

Conclusions:

• OXPHOS deficits, particularly involving Complex I, are significantly implicated in SCZ pathophysiology.
• Understanding OXPHOS dysfunction offers new insights into SCZ etiology and potential therapeutic targets.
• Complex I's interaction with dopamine and antipsychotics further supports its role in SCZ.